Sharecare Management

Management Kriterienprüfungen 2/4

Sharecare's CEO ist Brent Layton, ernannt in Jan 2024, hat eine Amtszeit von weniger als ein Jahr. besitzt direkt 0.14% der Aktien des Unternehmens, im Wert von €373.23K. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.3 Jahre bzw. 2.8 Jahre.

Wichtige Informationen

Brent Layton

Geschäftsführender

US$235.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	less than a year
Eigentum des Geschäftsführers	0.2%
Durchschnittliche Amtszeit des Managements	3.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	2.9yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Brent Layton (55 yo)

less than a year

Amtszeit

US$235,000

Vergütung

Mr. Brent Davis Layton serves as Director of Homeward Health Inc. since June 2023. He is Director at Sharecare, Inc. from January 11, 2023 and is its CEO since January 2, 2024. He was Senior Advisor to the...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jeffrey Arnold	Founder & Executive Chairman	12.4yrs	US$18.19m	2.72% $ 7.4m
Brent Layton	CEO & Director	less than a year	US$235.00k	0.17% $ 469.4k
Dawn Whaley	President & Chief Marketing Officer	14.4yrs	US$7.28m	0.39% $ 1.1m
Justin Ferrero	President & CFO	14.4yrs	US$7.27m	0.37% $ 1.0m
Shannon Bagley	Chief Operating Officer	no data	keine Daten	keine Daten
Michael Blalock	Chief Accounting Officer & Principal Accounting Officer	2.4yrs	keine Daten	0.030% $ 82.9k
Harsha Panyadahundi	Chief Technology Officer	1.9yrs	keine Daten	keine Daten
Walter De Brouwer	Chief Scientific Officer	3.3yrs	keine Daten	keine Daten
Colin Daniel	Chief Administrative Officer	2.4yrs	keine Daten	0.099% $ 269.9k
Henry Jay	General Counsel & Diversity Officer	no data	keine Daten	keine Daten
Jen Hall	Executive Vice President of Corporate Communications	3.4yrs	keine Daten	keine Daten
Dermot Waters	Executive Vice President of Marketing	3.4yrs	keine Daten	keine Daten

3.4yrs

Durchschnittliche Betriebszugehörigkeit

53.5yo

Durchschnittliches Alter

Erfahrenes Management: 8DJ0Das Führungsteam des Unternehmens gilt als erfahren (3.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jeffrey Arnold	Founder & Executive Chairman	12.4yrs	US$18.19m	2.72% $ 7.4m
Brent Layton	CEO & Director	1.4yrs	US$235.00k	0.17% $ 469.4k
Michael Roizen	Member of Advisory Board	no data	keine Daten	keine Daten
John Chadwick	Lead Independent Director	2.9yrs	US$290.00k	0.088% $ 239.3k
Jeffrey Allred	Independent Director	2.9yrs	US$252.54k	0.19% $ 530.9k
Vincent DeVita	Member of Advisory Board	no data	keine Daten	keine Daten
Tanya Altmann	Member of Advisory Board	no data	keine Daten	keine Daten
Barbara Ficarra	Member of Advisory Board	no data	keine Daten	keine Daten
Arthur Crowley	Member of Advisory Board	no data	keine Daten	keine Daten
David Demartini	Member of Advisory Board	no data	keine Daten	keine Daten
Patricia Geraghty	Member of Advisory Board	no data	keine Daten	keine Daten
Sandro Galea	Independent Director	2.9yrs	US$253.23k	0.039% $ 105.4k

2.9yrs

Durchschnittliche Betriebszugehörigkeit

55.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 8DJ0Die Vorstandsmitglieder gelten nicht als erfahren ( 2.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.

Sharecare Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. Announces CEO Changes

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Recent updates

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Sharecare, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. Announces CEO Changes

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Second quarter 2023 earnings released: US$0.099 loss per share (vs US$0.084 loss in 2Q 2022)

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings released: US$0.098 loss per share (vs US$0.11 loss in 1Q 2022)

Full year 2022 earnings released: US$0.34 loss per share (vs US$0.30 loss in FY 2021)

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings released: US$0.078 loss per share (vs US$0.13 loss in 3Q 2021)

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Second quarter 2022 earnings released: US$0.084 loss per share (vs US$8.77 loss in 2Q 2021)

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

No longer forecast to breakeven

First quarter 2022 earnings released: US$0.11 loss per share (vs US$14.23 loss in 1Q 2021)

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings released: US$0.30 loss per share (vs US$28.48 loss in FY 2020)

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Forecast to breakeven in 2023

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter